Table 4.
During hospitalization | |
Oxygen therapy | Continuous low-flow oxygen absorption (oxygen concentration is 2 L/min). |
Short-acting inhaled bronchodilator | Albuterol atomization solution 5 mg, ipratropium bromide atomization solution 500μg, nebulization, Bid. |
Theophylline | Aminophylline 0.5 g for injection, intravenous drip, Qd; Peony ambroxol 60 mg, intravenous drip, Bid. |
Antibiotics | Penicillins: piperacillin tazobactam 4.5 g, intravenous infusion, Q8h; quinolines: levofloxacin injection 0.5 g, intravenous infusion, Qd. Antibiotics for 7–10 days. |
After discharge | |
Group A use a bronchodilator | |
Group B use LAMA or LABA | |
Group C use LAMA | |
Group D use LAMA and/or LABA+ICS |
Group A to D is classified according to the 2019 GOLD guideline
LAMA long-acting anti-muscarinic antagonists, LABA long-acting beta2-agonists, ICS inhaled corticosteroids